Ilevro Suspension/ Drops
Product Images NDC 0078-0743

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ilevro (NDC 0078-0743). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel Ndc 0078-0743-03 Sterile Ilevro® (nepafenac Ophthalmic Suspension) 0.3% 3 mL Rx Only Novartis (Carton)

Packaging label for ILEVRO (nepafenac ophthalmic suspension) 0.3%, 3 mL. The label shows it is a prescription ophthalmic suspension manufactured by S/A Alcon-Couvreur NV in Belgium and distributed by Novartis Pharmaceuticals Corporation. Instructions for use include topical ophthalmic application and storage conditions. Barcodes and regulatory text are present.*

FDA Label Image

Structural Formula Of Nepafenac (Chemical)

Chemical structure diagram of nepafenac, the active ingredient in ILEVRO 3 mg/mL ophthalmic suspension by Novartis Pharmaceuticals Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.